ATARA BIOTHERAPEUTICS, INC.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $3.2M $8.4M $8.5M $5.7M $16.9M $13.8M $25.0M $46.5M
Accounts Receivable $318.0K $0 $1.3M $1.9M $0 $8.9M $1.5M $1.3M
Inventory $0 $0 $0 $0 $10.7M $14.0M
Total Current Assets $13.5M $12.2M $12.2M $18.4M $24.8M $27.2M $64.9M $91.9M
Property, Plant & Equipment $41.0K $55.0K $73.0K $147.0K $176.0K $285.0K $1.3M $1.7M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $21.0M $20.0M $20.2M $30.2M $36.9M $62.0M $109.1M $142.7M
Liabilities
Accounts Payable $824.0K $637.0K $127.0K $318.0K $1.8M $1.4M $4.4M $2.1M
Total Current Liabilities $6.8M $5.6M $14.9M $18.1M $14.6M $47.9M $134.6M $156.0M
Long-Term Debt
Total Liabilities $58.0M $57.3M $58.7M $66.8M $71.9M $117.1M $206.4M $233.2M
Stockholders' Equity
Retained Earnings $-2.03B $-2.03B $-2.02B $-2.02B $-2.01B $-2.02B $-2.05B $-2.04B
Total Stockholders' Equity $-37.0M $-37.3M $-38.5M $-36.6M $-35.0M $-55.1M $-97.3M $-90.5M
← Newer Page 1 of 7 Older →